# US 2004/0081963 A1 · Sso7-polymerase conjugate proteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0081963 A1
- Document ID: US20040081963A1
- Status: Published application
- Kind: A1
- Application number: 10/280,139
- Filed: 2002-10-23
- Published: 2004-04-29
- Earliest claimed: 2002-10-23
- Assignees: MJ Bioworks Incorporated
- Inventors: Yan Wang
- Web page: https://patentgrep.com/patent/US20040081963A1

## CPC

- C12N 9/1252: {DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase}
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

This invention provides Sso7-polymerase conjugates that exhibit improved activity in a polymerase reaction.

## Claims

### Claim 1

An Sso7 polymerase conjugate protein comprising an Sso7 domain having at least 60% identity to SEQ ID NO:2 linked to a polymerase domain; wherein an amino acid at a position that is a face residue position as determined with reference to SEQ ID NO:2, is substituted with a different amino acid residue;
wherein replacement of the face residue results in a processivity that is less than the processivity of a wildtype Sso7-polymerase fusion and greater than the processivity of the polymerase domain when it is not fused to an Sso7d domain.

### Claim 2 (depends on 1)

The Sso7 polymerase conjugate protein of claim 1, wherein the face residue position is selected from the group consisting of a tryptophan residue at position 24, a valine residue at position 26, and a methionine residue at position 29.

### Claim 3 (depends on 2)

The Sso7 polymerase conjugate protein of claim 2, wherein the face residue position is a tryptophan residue at position 24, and the replacement amino acid residue is any amino acid other than Asp, Glu, Arg, Lys, or Pro.

### Claim 4 (depends on 3)

The Sso7 polymerase conjugate protein of claim 3, wherein the replacement amino acid residue is selected from the group consisting of glycine, valine, and alanine.

### Claim 5 (depends on 4)

The Sso7 polymerase conjugate protein of claim 4, wherein the replacement amino acid residue is glycine.

### Claim 6 (depends on 4)

The Sso7 polymerase conjugate protein of claim 4, wherein the amino acid residue is valine.

### Claim 7 (depends on 1, 2, 3, 4, 5)

The Sso7 polymerase conjugate protein of any of claims 1, 2, 3, 4, 5, or 6, wherein the polymerase domain has thermally stable polymerase activity.

### Claim 8 (depends on 7)

The Sso7 polymerase conjugate protein of claim 7, wherein the polymerase domain is a family A polymerase domain.

### Claim 9 (depends on 8)

The Sso7 polymerase conjugate protein of claim 8, wherein the polymerase domain is a ΔTaq polymerase domain.

### Claim 10 (depends on 7)

The Sso7 polymerase conjugate protein of claim 7, wherein the polymerase domain is a polymerase B family member.

### Claim 11 (depends on 10)

The Sso7 polymerase conjugate protein of claim 10, wherein the polymerase domain is a Pyrococcus polymerase domain.

### Claim 12 (depends on 1)

The Sso7 polymerase conjugate protein of claim 1, wherein the Sso7 domain comprises SEQ ID NO:2 in which an amino acid at a position that is a face residue position is replaced by a different amino acid.

### Claim 13 (depends on 1)

The Sso7 polymerase conjugate protein of claim 1, wherein the Sso7 domain comprises SEQ ID NO:2 in which a tryptophan residue at position 24 is replaced with an amino acid residue selected from a group consisting of glycine, alanine, and valine.

### Claim 14 (depends on 1)

The Sso7 polymerase conjugate protein of claim 1, wherein replacement of the face residue increases the polymerase primer/template binding specificity in comparison to an Sso7 polymerase fusion protein comprising SEQ ID NO:2.

### Claim 15 (depends on 14)

The Sso7 polymerase conjugate protein of claim 14, wherein the face residue position is selected from the group consisting of a tryptophan residue at position 24, a valine residue at position 26, and a methionine residue at position 29.

### Claim 16 (depends on 15)

The Sso7 polymerase conjugate protein of claim 15, wherein the face residue position is a tryptophan residue at position 24, and the replacement amino acid residue is any amino acid other than Asp, Glu, Arg, Lys, or Pro.

### Claim 17 (depends on 16)

The Sso7 polymerase conjugate protein of claim 16, wherein the replacement amino acid residue is selected from the group consisting of glycine, valine, and alanine.

### Claim 18 (depends on 17)

The Sso7 polymerase conjugate protein of claim 17, wherein the replacement amino acid residue is glycine.

### Claim 19 (depends on 17)

The Sso7 polymerase conjugate protein of claim 17, wherein the amino acid residue is valine.

### Claim 20 (depends on 14, 15, 16, 17, 18)

The Sso7 polymerase conjugate protein of any of claims 14, 15, 16, 17, 18, or 19, wherein the polymerase domain has thermally stable polymerase activity.

### Claim 21 (depends on 20)

The Sso7 polymerase conjugate protein of claim 20, wherein the polymerase domain is a family A polymerase domain.

### Claim 22 (depends on 21)

The Sso7 polymerase conjugate protein of claim 21, wherein the polymerase domain is a ΔTaq polymerase domain.

### Claim 23 (depends on 14)

The Sso7 polymerase conjugate protein of claim 14, wherein the Sso7 domain comprises SEQ ID NO:2 in which an amino acid at a position that is a face residue position is replaced by a different amino acid.

### Claim 24 (depends on 14)

The Sso7 polymerase conjugate protein of claim 14, wherein the Sso7 domain comprises SEQ Id NO:2 in which a tryptophan residue at position 24 is replaced with an amino acid residue selected from the group consisting of glycine, alanine, and valine.

### Claim 25

A method of modulating a polymerase reaction on a target nucleic acid present in a solution, the method comprising:
(a) contacting the target nucleic acid with a an Sso7 polymerase conjugate protein comprising an Sso7 domain having at least 60% identity to SEQ ID NO:2 linked to a polymerase domain; wherein an amino acid at a position that is a face residue position as determined with reference to SEQ ID NO:2, is replaced by an amino acid residue that does not occur at the face residue position in a wildtype Sso7 protein; and wherein replacement of the face residue results in a processivity that is greater than the processivity of the polymerase domain when it is not fused to an Sso7 domain;
wherein the solution is of a composition that permits the binding domain to bind to the target nucleic acid and the polymerase domain to extend a primer that is hybridized to the target nucleic acid sequence;
(b) incubating the solution under conditions in which the primer is extended by the polymerase.

### Claim 26 (depends on 25)

The method of claim 25, further wherein replacement of the face residue increases the polymerase primer/tem0plate binding specificity in comparison to an Sso7 polymerase fusion protein comprising SEQ ID NO:2.

### Claim 27 (depends on 25)

The method of claim 25, wherein the face residue is selected from the group consisting of a tryptophan residue at position 24, a valine residue at position 26, and a methionine residue at position 29.

### Claim 28 (depends on 27)

The method of claim 27, wherein the face residue is a tryptophan residue at position 24, and the replacement residue is neutral or positive in charge with a side chain volume is less than the side chain volume of tryptophan.

### Claim 29 (depends on 28)

The method of claim 28, wherein the amino acid residue is selected from the group consisting of glycine, valine, and alanine.

### Claim 30 (depends on 29)

The method of claim 29, wherein the amino acid residue is glycine.

### Claim 31 (depends on 29)

The method of claim 29, wherein the amino acid residue is valine.

### Claim 32 (depends on 25)

The method of claim 25, wherein the polymerase domain has thermally stable polymerase activity.

### Claim 33 (depends on 32)

The method of claim 32, wherein the polymerase domain is a family A polymerase domain.

### Claim 34 (depends on 32)

The method of claim 32, wherein the polymerase domain is a family B polymerase domain.

### Claim 35 (depends on 32)

The method of claim 32, wherein the polymerase domain is a ΔTaq polymerase domain.

### Claim 36 (depends on 25)

The method of claim 25, wherein the Sso7 domain comprises SEQ ID NO:2 in which a tryptophan residue at position 24 is replaced with an amino acid residue selected from a group consisting of glycine, alanine, and valine.
